ITMI922331A1 - Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione - Google Patents

Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Info

Publication number
ITMI922331A1
ITMI922331A1 IT002331A ITMI922331A ITMI922331A1 IT MI922331 A1 ITMI922331 A1 IT MI922331A1 IT 002331 A IT002331 A IT 002331A IT MI922331 A ITMI922331 A IT MI922331A IT MI922331 A1 ITMI922331 A1 IT MI922331A1
Authority
IT
Italy
Prior art keywords
abortion
therapy
prevention
treatment
general
Prior art date
Application number
IT002331A
Other languages
English (en)
Inventor
Franco Bagnoli
Original Assignee
Franco Bagnoli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Franco Bagnoli filed Critical Franco Bagnoli
Publication of ITMI922331A0 publication Critical patent/ITMI922331A0/it
Priority to ITMI922331A priority Critical patent/IT1255723B/it
Priority to EP93922531A priority patent/EP0663835B1/en
Priority to KR1019950701350A priority patent/KR100293846B1/ko
Priority to NZ256679A priority patent/NZ256679A/en
Priority to ES93922531T priority patent/ES2103493T3/es
Priority to DE69310528T priority patent/DE69310528T2/de
Priority to US08/411,726 priority patent/US5880093A/en
Priority to PCT/EP1993/002755 priority patent/WO1994008613A2/en
Priority to AT93922531T priority patent/ATE152628T1/de
Priority to CA002146666A priority patent/CA2146666A1/en
Priority to AU51499/93A priority patent/AU680631B2/en
Priority to JP6509588A priority patent/JPH08502271A/ja
Priority to DK93922531.4T priority patent/DK0663835T3/da
Publication of ITMI922331A1 publication Critical patent/ITMI922331A1/it
Priority to NO19951050A priority patent/NO317930B1/no
Application granted granted Critical
Publication of IT1255723B publication Critical patent/IT1255723B/it
Priority to GR970401802T priority patent/GR3024157T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
ITMI922331A 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione IT1255723B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
AT93922531T ATE152628T1 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
AU51499/93A AU680631B2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
NZ256679A NZ256679A (en) 1992-10-09 1993-10-08 Use of parathormone (parathyroid hormone) in prevention and therapy of abortion and of premature birth
ES93922531T ES2103493T3 (es) 1992-10-09 1993-10-08 Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
DE69310528T DE69310528T2 (de) 1992-10-09 1993-10-08 Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
US08/411,726 US5880093A (en) 1992-10-09 1993-10-08 Use of parathormone, its biologically active fragments and correlated peptides, for the preparation of pharmaceutical compositions useful for the treatment of pregnancy
PCT/EP1993/002755 WO1994008613A2 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
EP93922531A EP0663835B1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
CA002146666A CA2146666A1 (en) 1992-10-09 1993-10-08 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy
KR1019950701350A KR100293846B1 (ko) 1992-10-09 1993-10-08 임신치료를위한파라소먼,그생물학적활성프래그먼트및관련펩티드의용도
JP6509588A JPH08502271A (ja) 1992-10-09 1993-10-08 パラトルモン、その生物学的活性フラグメント及び関連ペプチドの妊娠時の治療への使用
DK93922531.4T DK0663835T3 (da) 1992-10-09 1993-10-08 Anvendelse af parathormon, dets biologisk aktive fragmenter og relaterede peptider til behandling af graviditet
NO19951050A NO317930B1 (no) 1992-10-09 1995-03-20 Anvendelse av paratyroidhormon, dets biologisk aktive fragmenter og korrelerte peptider for fremstilling av farmasoytiske blandinger for behandling under svangerskap.
GR970401802T GR3024157T3 (en) 1992-10-09 1997-07-17 Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Publications (3)

Publication Number Publication Date
ITMI922331A0 ITMI922331A0 (it) 1992-10-09
ITMI922331A1 true ITMI922331A1 (it) 1994-04-09
IT1255723B IT1255723B (it) 1995-11-13

Family

ID=11364090

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI922331A IT1255723B (it) 1992-10-09 1992-10-09 Uso di paratormone,suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione

Country Status (14)

Country Link
US (1) US5880093A (it)
EP (1) EP0663835B1 (it)
JP (1) JPH08502271A (it)
KR (1) KR100293846B1 (it)
AT (1) ATE152628T1 (it)
AU (1) AU680631B2 (it)
CA (1) CA2146666A1 (it)
DE (1) DE69310528T2 (it)
DK (1) DK0663835T3 (it)
ES (1) ES2103493T3 (it)
GR (1) GR3024157T3 (it)
IT (1) IT1255723B (it)
NZ (1) NZ256679A (it)
WO (1) WO1994008613A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496801A (en) * 1993-12-23 1996-03-05 Allelix Biopharmaceuticals Inc. Parathyroid hormone formulation
WO1996025944A1 (fr) 1995-02-20 1996-08-29 Yukio Kato Remedes contre la polyarthrite rhumatoide et les affections articulaires inflammatoires
SE9702401D0 (sv) 1997-06-19 1997-06-19 Astra Ab Pharmaceutical use
US6043981A (en) * 1997-11-13 2000-03-28 Chrysler Corporation Heat sink assembly for electrical components
MY120063A (en) † 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
US6770623B1 (en) 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
US6495662B1 (en) * 1998-10-22 2002-12-17 The General Hospital Corporation Bioactive peptides and peptide derivatives of parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP)
AU7734800A (en) * 1999-09-29 2001-04-30 General Hospital Corporation, The Polypeptide derivatives of parathyroid hormone (pth)
US7572765B2 (en) * 2001-07-23 2009-08-11 The General Hospital Corporation Conformationally constrained parathyroid hormone (PTH) analogs
US7378495B2 (en) * 2002-10-21 2008-05-27 Pevion Biotech, Ltd. PTH-rP related peptide cancer therapeutics
AU2003217243A1 (en) * 2003-01-24 2004-08-23 Thomas J. Gardella Conformationally constrained parathyroid hormone (pth) analogs with lactam bridges
EP1610813A4 (en) * 2003-03-19 2009-07-01 Gen Hospital Corp CONFORMATION RESTRICTED PARATHORMONE WITH A HELIX STABILIZERS
EP1653985A4 (en) 2003-07-17 2009-08-05 Gen Hospital Corp FORCED PARATHORMON (PTH) ANALOGUE
ES2568259T3 (es) 2004-05-13 2016-04-28 Alza Corporation Aparato y método para la administración transdérmica de agentes de hormona paratiroidea
CA2567942A1 (en) * 2004-05-26 2005-12-08 Green Peptide Co., Ltd. Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein
WO2008019062A2 (en) * 2006-08-04 2008-02-14 The General Hospital Corporation Polypeptide derivatives of parathyroid hormone (pth)
BRPI0814962B8 (pt) * 2007-08-01 2021-05-25 Chugai Pharmaceutical Co Ltd métodos in vitro para determinar se um composto candidato é um agonista de longa duração ou de curta duração de um receptor acoplado à proteína g, polipeptídeo, seu uso e composição farmacêutica
EP2569003B1 (en) 2010-05-13 2017-10-25 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3090353B2 (ja) * 1991-09-17 2000-09-18 旭化成工業株式会社 パラチロイドホルモン類含有経鼻投与用乳剤
KR0131678B1 (ko) * 1991-12-09 1998-04-17 유미꾸라 레이이찌 파라티로이드 호르몬류의 안정화 조성물
US5382658A (en) * 1992-04-03 1995-01-17 Allelix Biopharmaceuticals Inc. Stability-enhanced variants of parathyroid hormone

Also Published As

Publication number Publication date
CA2146666A1 (en) 1994-04-28
AU680631B2 (en) 1997-08-07
WO1994008613A2 (en) 1994-04-28
DK0663835T3 (da) 1997-09-01
ATE152628T1 (de) 1997-05-15
JPH08502271A (ja) 1996-03-12
EP0663835B1 (en) 1997-05-07
GR3024157T3 (en) 1997-10-31
DE69310528D1 (de) 1997-06-12
EP0663835A1 (en) 1995-07-26
ES2103493T3 (es) 1997-09-16
IT1255723B (it) 1995-11-13
KR100293846B1 (ko) 2001-09-17
AU5149993A (en) 1994-05-09
US5880093A (en) 1999-03-09
KR950703359A (ko) 1995-09-20
DE69310528T2 (de) 1997-09-11
WO1994008613A3 (en) 1994-05-26
ITMI922331A0 (it) 1992-10-09
NZ256679A (en) 1997-03-24

Similar Documents

Publication Publication Date Title
ITMI922331A1 (it) Uso di paratormone, suoi frammenti biologicamente attivi e peptidi correlati, per la preparazione di composizioni farmaceutiche utili nella prevenzione e terapia dell'aborto e del parto pretermine ed in generale per il trattamento della gestazione
IT1252868B (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
ES2113635T3 (es) Aplicacion del riluzole en el tratamiento de lesiones neurologicas relacionadas con traumatismos.
IL112112A (en) Peptides with growth hormone releasing properties and pharmaceutical compositions containing them
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
PL329802A1 (en) Derivatives of androstene
MX173567B (es) Procedimiento para preparar una composicion farmaceutica y composicion farmaceutica para mejorar los sintomas de enfermedad inducida por vih o reducir la transcripcion y proliferacion del vih
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
SE9502219D0 (sv) Novel medical use
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
DK0673376T3 (da) Bicykliske pyrimidinforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som omfatter dem
DK0713386T3 (da) Sprayformulering med kølende effekt
YU13599A (sh) Primena farmaceutske kompozicije za dobijanje leka u obliku gela
FR2710844B1 (fr) Composition pour le traitement ou la prévention de l'herpès.
ES2157984T3 (es) Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis.
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
IL107917A0 (en) Triazoloquinazolines, their preparation and their use as medicaments
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
AP2001002167A0 (en) Use of 17-ketosteroids for the treatment of toxoplasmosis and crytosporidiosis
ZA9427B (en) Use of riluzole for promoting restoration following radiation
PE20011042A1 (es) Uso de glutamina para la prevencion de diarrea de inicio tardio inducida por irinotecan
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030